Skip to main content
. 2009 Sep 1;42(6):788–798. doi: 10.1111/j.1365-2184.2009.00640.x

Figure 3.

Figure 3

  Effect of day 1, day 2, day 3 mouse primary embryonic fibroblast (MEF) + human embryonic stem cell conditioned medium (hESC CM) on cancer and human embryonic fibroblast cell proliferation. Breast cancer (MCF‐7 and T47D), prostate cancer (PC3 and DU145) and human embryonic fibroblasts were treated with day 1, day 2, day 3 MEF CM or MEF + hESC CM for 24–72 h. Cell number was determined by MTT assay (a–e). *Significantly different from control values (P < 0.05). Bars represent the mean ± standard error of the mean of eight replicates.